Year Authors/Creators Item Type Full Text

C

The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence. (2022) Carle, Chelsea; Hughes, Suzanne; Freeman, Victoria; Campbell, Denise; Egger, Sam; Caruana, Michael; Hui, Harriet; Yap, Sarsha; Deandrea, Silvia; Onyeka, Tonia C; IJzerman, Maarten J; Ginsburg, Ophira; Bray, Freddie; Sullivan, Richard; Aggarwal, Ajay; Peacock, Stuart J; Chan, Kelvin KW; Hanna, Timothy P; Soerjomataram, Isabelle; O'Connell, Dianne L; Canfell, Karen; Steinberg, Julia

F

Association between COVID-19 burden and delays to diagnosis and treatment of cancer patients in England. (2022) Fox, Louis; Monroy-Iglesias, Maria J; Aggarwal, Ajay; Haire, Kate; Purushotham, Arnie; Spicer, James; Papa, Sophie; Rigg, Anne; Dolly, Saoirse; Sullivan, Richard; Van Hemelrijck, Mieke

K

Analysis of factors associated with use of real-world data in single technology appraisals of cancer drugs by the National Institute for Health and Care Excellence. (2024) Kang, Jiyeon; Cairns, John

M

Understanding the link between health systems and cancer survival: A novel methodological approach using a system-level conceptual model. (2020) Morris, Melanie; Landon, Susan; Reguilon, Irene; Butler, John; McKee, Martin; Nolte, Ellen description

P

Why do some countries approve a cancer drug and others don’t? (2015) Pujolras, Laia Maynou; Cairns, John

S

How can clinical research improve European health outcomes in cancer? (2019) Selby, Peter; Liu, Lifang; Downing, Amy; Banks, Ian; Wilson, Roger; Stephens, Richard; Meunier, Francoise; Rochon, Justine; Morris, Eva; Seymour, Matt; Gregory, Walter; Lawler, Mark; Boaz, Annette